Calf Augmentation in Minnesota
Calf Augmentation in Minnesota section, includes general infrmation about Calf Augmentation Procedure, Calf Augmentation Minnesota Local News, Calf Augmentation Minnesota Surgeon Locator and other Calf Augmentation related material.
Calf Augmentation Procedure
This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.
This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.
Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.
After the surgery you may feel some degree of pain. Your doctor'll subscribe you for painkillers. At the first two days you'll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you'll fell like you're calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You'll be able to go back to work after 7-10 days. You'll get detailed instructions from you're surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.
Other Calf Augmentation Procedures
All Body Procedures
Calf Augmentation Minnesota (current)
Calf Augmentation Minnesota Buttock Augmentation
Calf Augmentation Minnesota Bariatric surgery
Calf Augmentation Minnesota Liposuction
Calf Augmentation Minnesota Body Contouring
More Minnesota info...
Minnesota Regions
Twin Cities
Northwestern Minnesota
Northeastern Minnesota
Southern Minnesota
Minnesota Twin Cities
Walker Art Center [6] and adjacent Sculpture Garden, near downtown Minneapolis.
Science Museum of Minnesota [7], in downtown Saint Paul.
Guthrie Theater, newly opened, June 2006
Plastic Surgery News...
- According to a report by BioSpace, Abraxis Inc. has announced that it has received European marketing approval for an albumin-bound nanoparticle formulation of paclitaxel (Abraxane) for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.
According to the report, the approval is based on the results of a phase III study which showed that the albumin-bound formulation of paclitaxel was linked to a higher response rate and prolonged progression-free and overall survival compared to patients who received conventional paclitaxel (Taxol). The following results were reported in the abstract:
• 26.5% (95% confidence interval 18.98 to 34.05) of patients in the Abraxane group achieved a response compared to 13.2% (7.54 to 18.93) of patients in the Taxol group (p=0.006)
• The median time to disease progression was 20.9 weeks (15.7 to 25.9) for patients on Abraxane compared to 16.1 weeks (15.0 to 19.3) for patients on Taxol (p=0.011)
• The median progression free survival time was 20.6 weeks (15.6 to 25.9) for patients on Abraxane and 16.1 weeks (15.0 to 18.3) for patients on Taxol (p=0.010)
• Overall survival was 56.4 weeks (45.1 to 76.9) for patients on Abraxane and 46.7 weeks (39.0 to 55.3) for patients on Taxol (p=0.020)
• The most serious adverse events associated with Abraxane in study included neutropenia, anaemia, infections, sensory neuropathy, nausea, vomiting and myalgia and arthralgia. Other common adverse reactions included asthenia, diarrhoea, ocular/visual disturbances, fluid retention, alopecia, hepatic dysfunction, mucositis and renal dysfunction.
The manufacturer expects to launch the product in mid-2008.
- Robert A. Star, M.D., has been named director of the Division
of Kidney, Urologic, and Hematologic Diseases at the National Institute
of Diabetes and Digestive and Kidney Diseases, by Institute Director
Dr. Griffin P. Rodgers.